We expect Judge Pratter to be impressive this week at her first status conference in the Ozempic litigation and show the lawyers that she is going to run a tight ship
So: It is not a stretch to say we shouldnt even refer to these as weight loss drugs, at least exclusively
Could once-daily therapy replace twice-daily dosing
Supplementary Information Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
Here's the projected timeline: What Could Change the Timeline Priority review: If the FDA grants priority review status (for drugs that show significant improvement over existing treatments), the review time drops to 6 months instead of 1012